Faculty Agenda Venue Faculty Slides
Saturday Jan 21, 2023 |
||
|
10.00 AM |
OPENING CEREMONY: WELCOME, INTRODUCTIONS |
|
|
Session 1: CV Prevention |
Moderator: Ron Blankstein |
|
|
10.15 am |
Is there a role for Triglyceride Lowering? |
Sadiya S. Khan |
|
10.35 am |
Non-statin therapies to reduce LDL-Cholesterol |
Ron Blankstein |
|
10.55 am |
When to add a GLP1-RA, SGLT2i, or both? |
Thomas Stephen Metkus |
|
11.15 am |
Premature CAD. Role of Genetic Testing and PRS |
Nosheen Reza |
|
11.35 am |
Faculty Q&A |
|
|
Session 2: Acute Coronary Syndromes |
Moderator: Eric R. Bates |
|
|
12.00 pm |
Biomarker Strategies to diagnose NSTEMI |
Thomas Stephen Metkus |
|
12.20 pm |
How to Incorporate Imaging into Chest Pain Assessment |
Ron Blankstein |
|
12.40 pm |
STEMI with multi-vessel disease |
Eric R. Bates |
|
1.00 pm |
Recommendations for Anti-Platelet Therapy after PCI for ACS |
Eric R. Bates |
|
1.20 pm |
Faculty Q&A |
|
|
1.30 pm |
Lunch |
|
|
Session 3: Chronic Coronary Syndromes |
Moderator: Sadiya S. Khan |
|
|
2.30 pm |
Long Term Anti-thrombotic and Medical Therapy |
Eric R. Bates |
|
2.50 pm |
Revascularization: When is CABG preferred over PCI? |
Patrick T. O’Gara |
|
3.10 pm |
Microvascular disease |
Sadiya S. Khan |
|
3.30 pm |
Asymptomatic patient with CAC: Evaluation and management |
Ron Blankstein |
|
3.50 pm |
Faculty Q&A |
|
|
4.15 pm |
Coffee Break |
|
|
Session 4: Peripheral Artery Disease and Venous Thromboembolic Disease |
Moderator: Geoffrey Barnes |
|
|
4.40 pm |
Optimal Anti-thrombotic Therapy for PAD patients |
Geoffrey Barnes |
|
5.00 pm |
Aortic Aneurysm Disease |
Patrick T. O’Gara |
|
5.20 pm |
Risk based approach to treatment of PE |
Thomas Stephen Metkus |
|
5.40 pm |
Treatment and secondary prevention of VTE disease in cancer patients |
Geoffrey Barnes |
|
6.00 pm |
Faculty Q&A |
|
|
6.30 pm |
Program Adjourn |
|
Sunday Jan 22, 2023 |
||
| Session 5: Heart Failure | Moderator: Clyde Yancy | |
| 8.30 am | 4 pillars of GDMT for HFrEF | Clyde Yancy |
| 8.50 am | Guideline Recommended Treatment of HFpEF | Clyde Yancy |
| 9.20 am | Amyloid Cardiomyopathy | James E. Udelson |
| 9.40 am | Cardio-oncology: Immune Check Point Inhibitors, CAR-T Cell Therapy, Others | Nosheen Reza |
| Session 6: Valvular Heart Disease | Moderator: Patrick T. O’Gara | |
| 10.40 am | The asymptomatic Patient with Aortic Stenosis | Patrick T. O’Gara |
| 11.00 am | BAV Disease with Aortopathy | Geoffrey Barnes |
| 11.20 am | Intervention for MV disease: Catheter, Surgery, Other | James E. Udelson |
| 11.40 am | Isolated TR. When to fix? | Patrick T. O’Gara |
| 12.00 pm | Faculty Q&A | |
| 12.20 pm | Lunch Break | |
| Session 7: Atrial Fibrillation | Moderator: Hugh Calkins | |
| 1.10 pm | Catheter Ablation vs Drug Therapy For Rhythm Control of AF | Hugh Calkins |
| 1.30 pm | Managing Peri-Operative AF. Is it the same? | Susan S. Kim |
| 1.50 pm | Status of LAA Occlusion | Hugh Calkins |
| 2.10 pm | Challenges in OAC therapy: Age, BMI, Renal Function, Cost | Susan S. Kim |
| 2.30 pm | Faculty Q&A | |
| Session 8: Hypertension | Moderator: James E. Udelson | |
| 2.50 pm | Hypertensive Disorders of Pregnancy | Sadiya S. Khan |
| 3.10 pm | Hypertensive Emergencies | James E. Udelson |
| 3.30 pm | Resistant Hypertension | Clyde Yancy |
| 3.50 pm | Status of Renal Denervation | Patrick T. O’Gara |
| 4.10 pm | Faculty Q&A | |
| 4.30 PM | Program Adjourn | |
